RedHill Biopharma Ltd. ADR | Income Statement
Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
43.30
25,090.40
11.70
387.70
14,413.10
30,056.40
Cost of Goods Sold (COGS) incl. D&A
-
3,756.10
139.90
-
7,647.20
10,199.80
Gross Income
-
21,334.40
128.20
-
6,765.90
19,856.60
SG&A Expense
38,838.30
59,778.50
84,965.90
117,466.20
190,668.40
161,261.90
EBIT
38,881.60
38,444.10
85,094.10
117,247.40
183,902.50
141,405.30
Unusual Expense
194.90
715.40
3,061.60
3,316.70
17,416.60
1,434.50
Non Operating Income/Expense
324.90
1,012.40
823.70
103.70
1,597.10
600.40
Pretax Income
38,361.90
38,315.30
81,939.30
112,744.60
163,820.60
139,568.10
Consolidated Net Income
38,361.90
38,315.30
81,939.30
112,744.60
163,820.60
139,568.10
Net Income
38,361.90
38,315.30
81,939.30
112,744.60
163,820.60
139,568.10
Net Income After Extraordinaries
38,361.90
38,315.30
81,939.30
112,744.60
163,820.60
139,568.10
Net Income Available to Common
38,361.90
38,315.30
81,939.30
112,744.60
163,820.60
139,568.10
EPS (Basic)
0.61
0.43
0.74
0.88
0.94
0.60
Basic Shares Outstanding
62,379.00
86,610.00
110,814.00
128,513.70
176,579.00
231,204
EPS (Diluted)
0.61
0.46
0.75
0.91
0.93
0.60
Diluted Shares Outstanding
62,379.00
87,222.00
111,715.00
128,808.50
176,579.00
231,204
EBITDA
38,795.00
38,347.50
84,954.20
117,078.50
183,611.20
141,081.70
Non-Operating Interest Income
-
425.70
916.90
1,082.50
1,068.30
1,003.10
About RedHill Biopharma
View Profile
